US Stock MarketDetailed Quotes

KRYS Krystal Biotech

Watchlist
  • 201.580
  • +4.060+2.06%
Close Aug 23 16:00 ET
  • 201.580
  • 0.0000.00%
Post 19:18 ET
5.79BMarket Cap51.03P/E (TTM)

Krystal Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
70.28M
45.25M
50.7M
42.14M
8.56M
0
0
0
0
0
Operating revenue
--70.28M
--45.25M
--50.7M
--42.14M
--8.56M
--0
--0
--0
--0
--0
Cost of revenue
6.01M
2.42M
3.09M
2.87M
223K
0
0
0
0
0
Gross profit
64.28M
42.83M
47.61M
39.27M
8.33M
0
0
0
0
0
Operating expense
13.56%43.21M
1.91%37.02M
20.50%144.83M
3.92%36.13M
9.14%34.33M
32.33%38.05M
44.01%36.32M
76.05%120.2M
58.95%34.77M
100.94%31.45M
Selling and administrative expenses
6.65%27.63M
8.42%26.06M
26.59%98.4M
3.05%24.76M
18.87%23.7M
45.01%25.9M
51.09%24.04M
92.46%77.74M
86.76%24.03M
108.26%19.94M
-General and administrative expense
----
----
----
----
18.87%23.7M
----
----
----
----
108.26%19.94M
Research and development costs
28.32%15.58M
-10.83%10.96M
9.35%46.43M
5.86%11.37M
-7.70%10.63M
11.52%12.14M
31.93%12.29M
52.28%42.46M
19.23%10.74M
89.41%11.52M
Operating profit
155.37%21.07M
116.01%5.82M
19.11%-97.23M
109.02%3.14M
17.35%-25.99M
-32.33%-38.05M
-44.01%-36.32M
-76.05%-120.2M
-58.95%-34.77M
-100.94%-31.45M
Net non-operating interest income expense
54.59%7.48M
116.00%7.62M
333.33%22.62M
176.54%7.52M
320.99%6.74M
650.08%4.84M
1,271.98%3.53M
503.17%5.22M
3,784.29%2.72M
2,441.27%1.6M
Non-operating interest income
54.59%7.48M
116.00%7.62M
333.33%22.62M
176.54%7.52M
320.99%6.74M
--4.84M
1,271.98%3.53M
2,550.25%5.22M
3,784.29%2.72M
2,441.27%1.6M
Non-operating interest expense
----
----
--0
----
----
----
----
--0
----
----
Other net income (expense)
-12.5M
0.00%-12.5M
450.00%87.5M
0
100M
50.00%-12.5M
-25M
0
Special income (charges)
---12.5M
0.00%-12.5M
450.00%87.5M
--0
--100M
--0
50.00%-12.5M
---25M
--0
--0
-Less:Other special charges
--12.5M
0.00%12.5M
-450.00%-87.5M
--0
---100M
----
-50.00%12.5M
--25M
--0
----
Income before tax
148.31%16.05M
102.06%932K
109.21%12.9M
133.25%10.66M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
-91.48%-29.85M
Income tax
477K
1.97M
0
0
Net income
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
-91.48%-29.85M
Net income continuous Operations
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
-91.48%-29.85M
Minority interest income
Net income attributable to the parent company
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
-91.48%-29.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
-91.48%-29.85M
Basic earnings per share
143.20%0.54
101.70%0.03
107.29%0.4
125.60%0.32
346.15%2.88
-13.64%-1.25
11.56%-1.76
-75.40%-5.49
-31.58%-1.25
-67.14%-1.17
Diluted earnings per share
142.40%0.53
101.70%0.03
107.10%0.39
124.80%0.31
338.46%2.79
-13.64%-1.25
11.56%-1.76
-75.40%-5.49
-31.58%-1.25
-67.14%-1.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 70.28M45.25M50.7M42.14M8.56M00000
Operating revenue --70.28M--45.25M--50.7M--42.14M--8.56M--0--0--0--0--0
Cost of revenue 6.01M2.42M3.09M2.87M223K00000
Gross profit 64.28M42.83M47.61M39.27M8.33M00000
Operating expense 13.56%43.21M1.91%37.02M20.50%144.83M3.92%36.13M9.14%34.33M32.33%38.05M44.01%36.32M76.05%120.2M58.95%34.77M100.94%31.45M
Selling and administrative expenses 6.65%27.63M8.42%26.06M26.59%98.4M3.05%24.76M18.87%23.7M45.01%25.9M51.09%24.04M92.46%77.74M86.76%24.03M108.26%19.94M
-General and administrative expense ----------------18.87%23.7M----------------108.26%19.94M
Research and development costs 28.32%15.58M-10.83%10.96M9.35%46.43M5.86%11.37M-7.70%10.63M11.52%12.14M31.93%12.29M52.28%42.46M19.23%10.74M89.41%11.52M
Operating profit 155.37%21.07M116.01%5.82M19.11%-97.23M109.02%3.14M17.35%-25.99M-32.33%-38.05M-44.01%-36.32M-76.05%-120.2M-58.95%-34.77M-100.94%-31.45M
Net non-operating interest income expense 54.59%7.48M116.00%7.62M333.33%22.62M176.54%7.52M320.99%6.74M650.08%4.84M1,271.98%3.53M503.17%5.22M3,784.29%2.72M2,441.27%1.6M
Non-operating interest income 54.59%7.48M116.00%7.62M333.33%22.62M176.54%7.52M320.99%6.74M--4.84M1,271.98%3.53M2,550.25%5.22M3,784.29%2.72M2,441.27%1.6M
Non-operating interest expense ----------0------------------0--------
Other net income (expense) -12.5M0.00%-12.5M450.00%87.5M0100M50.00%-12.5M-25M0
Special income (charges) ---12.5M0.00%-12.5M450.00%87.5M--0--100M--050.00%-12.5M---25M--0--0
-Less:Other special charges --12.5M0.00%12.5M-450.00%-87.5M--0---100M-----50.00%12.5M--25M--0----
Income before tax 148.31%16.05M102.06%932K109.21%12.9M133.25%10.66M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M-91.48%-29.85M
Income tax 477K1.97M00
Net income 146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M-91.48%-29.85M
Net income continuous Operations 146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M-91.48%-29.85M
Minority interest income
Net income attributable to the parent company 146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M-91.48%-29.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M-91.48%-29.85M
Basic earnings per share 143.20%0.54101.70%0.03107.29%0.4125.60%0.32346.15%2.88-13.64%-1.2511.56%-1.76-75.40%-5.49-31.58%-1.25-67.14%-1.17
Diluted earnings per share 142.40%0.53101.70%0.03107.10%0.39124.80%0.31338.46%2.79-13.64%-1.2511.56%-1.76-75.40%-5.49-31.58%-1.25-67.14%-1.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg